What diseases can vitamin C prevent?

Vitamin C prevents exactly one disease, and it is one most people reading this are unlikely to get.

That disease is scurvy, and the amount that holds it off is small — around 10 mg a day, roughly a seventh of an orange.

Everything else on the long list of conditions vitamin C is said to prevent has been put through randomised trials, and most of those trials came back null. The gap between what the observational research suggested and what the trials found is where the useful information sits.

Table of Contents

1. What Diseases Can Vitamin C Prevent?
2. Scurvy: The One Disease on the List
3. Colds: The Most-Tested Claim of All
4. Heart Disease and Cancer: Two Large Trials, Two Null Results
5. Eye Disease: The Result That Looks Like Prevention
6. The Pattern Running Through All of It
7. Bio Absorb Liposomal Vitamin C
8. Frequently Asked Questions
9. Conclusion
10. Research References

1. What Diseases Can Vitamin C Prevent?

One: scurvy. That is the complete list of diseases that vitamin C supplementation has been shown to prevent in randomised controlled trials, and the threshold is low — overt deficiency requires intake to drop below about 10 mg a day for many weeks, against an adult RDA of 90 mg for men and 75 mg for women.

That answer tends to surprise people, because the observational literature is full of associations between higher vitamin C intake and lower rates of almost everything. Those associations are real, but they describe people who eat more fruit and vegetables, exercise more and smoke less. When researchers isolated the vitamin itself in trials running up to 10 years, the associations mostly dissolved.

The sections below work through each major claim in turn: colds, cardiovascular disease, cancer and eye disease. The conclusions differ in detail, but they converge on one idea, and it has more practical use than the list itself.

2. Scurvy: The One Disease on the List

Vitamin C is a required cofactor for the enzymes that stabilise collagen, so when it runs out the body loses the ability to maintain connective tissue. A clinical reference puts the first vague symptoms at 4 to 12 weeks of insufficient intake, with bleeding gums, easy bruising and corkscrew hairs following as the deficiency deepens.

This is prevention in the strict sense: the disease is caused by the absence of the nutrient, so supplying the nutrient prevents it. No other condition on the list has that relationship. The treatment response is correspondingly fast — with treatment, fatigue and aches typically improve within 24 hours.

Scurvy has also not gone away. On the standard definition of plasma below 11.4 µmol/L, 6.8% of US adults were deficient in 2017–2018, statistically unchanged from 7.0% in 2003–2006. The full picture of deficiency signs and who is at risk is worth reading if any of that sounds familiar.

3. Colds: The Most-Tested Claim of All

This is the claim with the deepest evidence base, and the answer is clearer than its reputation suggests. A Cochrane review restricted to placebo-controlled trials found no reduction in how often people caught colds across 29 trial comparisons involving 11,306 participants, and concluded that routine supplementation is not justified on that basis.

There is one exception, and it is informative. In five trials covering 598 marathon runners, skiers and soldiers on subarctic exercises, vitamin C roughly halved the risk of a cold (pooled RR 0.48, 95% CI 0.35–0.64). Those are people under extreme, sustained physical stress — not a typical office winter.

What the same review did find was a modest effect on how long colds last once they start, which is a different claim from prevention:

• No effect on cold incidence in the general population across 11,306 participants
• A pooled RR of 0.48 on incidence in 598 people under severe physical stress
• In children, 1 to 2 g a day shortened colds by about 18%
• Cold duration was assessed separately across 31 comparisons covering 9,745 episodes

Shortening an illness by a fifth is not the same as stopping it happening, and the distinction matters when deciding whether a daily supplement is worth it. There is more detail in our breakdown of what the cold and flu evidence actually shows.

4. Heart Disease and Cancer: Two Large Trials, Two Null Results

The Physicians' Health Study II is the most direct test anyone has run. It randomised 14,641 US male physicians aged 50 and over to 500 mg of vitamin C daily or placebo, ran from 1997 to 2007, and recorded 1,245 confirmed major cardiovascular events over a mean of eight years. The hazard ratio for vitamin C was 0.99 (P = .91).

The same cohort was analysed for cancer, with 1,008 confirmed prostate cancers and 1,943 total cancers over 8.0 years. Vitamin C showed no effect on either, and the authors wrote that the data give no support for using these supplements to prevent cancer in middle-aged and older men.

One published critique of the cardiovascular result is worth knowing, because it points somewhere useful rather than away. Researchers noted that physicians eating three servings of fruit or vegetables daily would already be consuming more than 100 mg a day — the point at which circulating immune cells are saturated. Adding 500 mg to an already-full tank would not be expected to change much. Our article on why most of your vitamin C dose is wasted covers the saturation mechanism in more depth.

5. Eye Disease: The Result That Looks Like Prevention

The Age-Related Eye Disease Study is the one place where something preventive-shaped appears, and it is also the most frequently over-claimed result in the whole field. AREDS enrolled 3,640 participants aged 55 to 80 and followed them for an average of 6.3 years, finding that antioxidants plus zinc reduced the odds of progressing to advanced macular degeneration in the higher-risk group (OR 0.66).

Four details change how that reads:

• The intervention was a four-ingredient formula — vitamin C, vitamin E, beta carotene and zinc — and vitamin C was not tested alone
• The benefit appeared in people who already had intermediate macular degeneration, or advanced disease in one eye
• The outcome was slowed progression, not prevented onset
• In the cataract arm of the same study, the National Eye Institute reports the nutrients had no significant effect on development or progression of age-related cataract

So the one eye condition where the formula helped was the one where participants were already ill, and the one where the question was onset rather than progression showed nothing across the same 6.3 years. That is a useful result for people with diagnosed macular degeneration and a weak basis for anyone else to take vitamin C as a preventive.

6. The Pattern Running Through All of It

Read together, these trials say something more specific than "vitamin C does not work". Where benefits appeared, participants had poor vitamin C status to begin with — the 598 people under severe physical stress, the 3,640 people with existing eye disease. Where results were null, as in the 14,641 well-fed physicians, participants were already replete.

That reframes the question from which diseases vitamin C prevents to whether a given person has enough. On the wider sufficiency threshold of 50 µmol/L, 41.8% of US adults fell short in the 2003–2006 survey data — a much larger group than the 6.8% who are clinically deficient, and the group where topping up plausibly changes something.

Getting there is less straightforward than swallowing a large dose, because absorption falls away as the dose climbs. Human pharmacokinetic work found absorption is complete at a single 200 mg dose, with plasma close to its maximum at around 200 mg a day. This is the reason delivery format gets discussed at all, and why our complete guide to liposomal vitamin C spends most of its length on absorption rather than on health claims.

7. Bio Absorb Liposomal Vitamin C — Built Around Status, Not Claims

Bio Absorb Nutraceuticals takes the position this article has arrived at: vitamin C is not a treatment for disease, and the honest case for supplementing it is about maintaining adequate status in people who fall short. That is why the product line is built around the absorption question rather than around a list of conditions.

A scoping review of liposomal formulations screened 321 studies and included 10, with nine of them showing 1.3 to 7.2-fold higher AUC for liposomal versus non-liposomal vitamin C. The same review is candid about what remains untested: none of the studies assessed elimination, and only two looked at potential biological effects. Better absorption is well evidenced; better health outcomes from that absorption have not been demonstrated.

Bio Absorb Nutraceuticals is a Canadian brand, GMP-certified and third-party tested every batch. Its Liposomal Vitamin C is available in two formats — a liquid that mixes with water or juice, and capsules that require no refrigeration — both verified corn-free, non-GMO, gluten-free, nut-free and vegan. Corn-free sourcing is the less common attribute here, since most commercial ascorbic acid is corn-derived.

Which one suits you comes down to how you like to take vitamin C. See current pricing and serving details for the liquid, or the same for the capsules.

Frequently Asked Questions

Does vitamin C prevent colds?

Not in the general population. A Cochrane review found no reduction in cold incidence across 29 trial comparisons involving 11,306 participants. The exception was people under severe physical stress, such as marathon runners and soldiers in subarctic conditions, where risk was roughly halved.

Can vitamin C prevent cancer or heart disease?

The trial evidence says no. In 14,641 men taking 500 mg daily for eight years, vitamin C had no effect on major cardiovascular events (HR 0.99) and no effect on 1,943 total cancers. Observational studies have found associations, but randomised trials have not reproduced them.

Is scurvy really the only disease vitamin C prevents?

On the randomised trial evidence, yes. Scurvy is caused directly by the absence of the vitamin, which appears when intake falls below roughly 10 mg a day. Other conditions have been associated with low vitamin C intake, but association is not the same as a preventable cause.

Does taking more vitamin C prevent more illness?

There is no evidence that it does, and absorption works against the idea — uptake is complete at a single 200 mg dose and declines as the dose rises. The tolerable upper intake level is 2,000 mg a day, above which gastrointestinal side effects become more likely; anyone with kidney problems, haemochromatosis or a regular medication should check with a doctor before taking more. Our article on high-dose vitamin C covers where that ceiling comes from.

Does liposomal vitamin C prevent diseases that regular vitamin C does not?

No. The evidence for liposomal delivery is about absorption, with nine of 10 studies showing 1.3 to 7.2-fold higher AUC. No trial has shown that the extra absorption translates into preventing any disease, and the prevention trials above used standard ascorbic acid.

Who actually benefits from a vitamin C supplement?

People whose intake or status is low. That includes the 6.8% of US adults who are clinically deficient and, more broadly, the 41.8% below the 50 µmol/L sufficiency threshold in the 2003–2006 survey data. Smokers need an extra 35 mg a day. Our guide to whether liposomal vitamin C is worth taking goes through the decision.

Conclusion

The honest answer to the question is one disease, and the amount that prevents it is about 10 mg a day. The more useful question is whether your own status is adequate, given that 41.8% of US adults fell below the sufficiency threshold in the 2003–2006 national survey data. If you have decided a supplement makes sense for you, see the current details on Bio Absorb's Liposomal Vitamin C.

Research References

1. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews, Issue 1 (2013), CD000980. Found no reduction in cold incidence across 29 trial comparisons involving 11,306 participants, with a pooled RR of 0.48 in people exposed to severe physical stress.
2. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA, Vol. 300, Issue 18 (2008). Randomised 14,641 male physicians to 500 mg vitamin C daily and found no effect on major cardiovascular events over a mean of eight years.
3. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA, Vol. 301, Issue 1 (2009). Recorded 1,008 prostate cancers and 1,943 total cancers across the same cohort, with no effect from vitamin C.
4. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology, Vol. 119, Issue 10 (2001). Source for the OR 0.66 reduction in progression to advanced AMD in higher-risk participants. The cataract result comes from the companion AREDS report no. 9 and is cited here to the National Eye Institute.
5. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1 (2025). Reports 1.3 to 7.2-fold higher AUC for liposomal forms in nine of ten trials, and the evidence gaps that remain.
6. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences, Vol. 93, Issue 8 (1996). Source for complete absorption at a single 200 mg dose, plasma close to maximum at 200 mg a day, and saturation of circulating immune cells at 100 mg a day.
7. Antioxidant supplements and cardiovascular disease in men. JAMA, Vol. 301, Issue 13 (2009), p. 1336, doi 10.1001/jama.2009.316. Argues the null result reflects a control group already replete in vitamin C, since participants eating three servings of fruit or vegetables daily would exceed 100 mg a day.
8. Vitamin C Status of US Adults Assessed as Part of the National Health and Nutrition Examination Survey Remained Unchanged between 2003–2006 and 2017–2018. Journal of Applied Laboratory Medicine, Vol. 8, Issue 2 (2023), p. 272. Source for 6.8% of US adults being deficient at plasma below 11.4 µmol/L, against 7.0% in 2003–2006.
9. Insufficient Vitamin C Levels among Adults in the United States: Results from the NHANES Surveys, 2003–2006. Nutrients, Vol. 13, Issue 11 (2021), article 3910. Defines the plasma status thresholds and reports that 41.8% of US adults fell below the 50 µmol/L sufficiency cut-off.
10. Vitamin C — Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements. Source for the approximate 10 mg/day deficiency threshold, the adult RDAs, the additional 35 mg/day for smokers, and the 2,000 mg/day Tolerable Upper Intake Level.
11. Vitamin C Deficiency. StatPearls, National Center for Biotechnology Information. Clinical reference for the 4 to 12 week symptom timeline, the physical signs of scurvy, and the speed of response to treatment.
12. Antioxidant Vitamins and Zinc Reduce Risk of Vision Loss from Age-Related Macular Degeneration. National Eye Institute, National Institutes of Health (2001). The trial sponsor's confirmation that the cataract arm found no significant effect.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.